Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Silo Pharma, Inc. issued 2,857,143 shares of common stock of common stock to unknown for purchase price of $0.875 per share.
- Security
- common stock
- Shares
- 2,857,143 shares of common stock
- Consideration
- purchase price of $0.875 per share
Exact text from the filing
and psychedelic treatments, today announced that it has entered into definitive agreements for the purchase and sale of 2,857,143 shares of common stock at a purchase price of $0.875 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Silo Pharma, Inc. issued warrants to purchase up to 2,857,143 shares of common stock of warrant to unknown for exercise price of $0.75 per share.
- Security
- warrant
- Shares
- warrants to purchase up to 2,857,143 shares of common stock
- Consideration
- exercise price of $0.75 per share
Exact text from the filing
In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 2,857,143 shares of common stock at an exercise price of $0.75 per share that will be immediately exercisable upon issuance and will expire five years from the effective date of a registration statement registering for resale the shares of common stock underlying the warrants.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Silo Pharma, Inc. issued shares of common stock underlying such unregistered warrants of common stock to unknown for upon exercise of warrants.
- Security
- common stock
- Shares
- shares of common stock underlying such unregistered warrants
- Consideration
- upon exercise of warrants
Exact text from the filing
The unregistered warrants described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying such unregistered warrants, have not been registered under the Securities Act, or applicable state securities laws.
View on SEC.gov